Form 6-K AIXTRON SE For: Jun 03
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
Report
of Foreign Private Issuer
Pursuant
to Rule 13a-16 or 15d-16 of the
Securities
Exchange Act of 1934
Commission
File No. 000-51196
For the
month of June, 2015
AIXTRON
SE
(Translation
of registrant’s name into English)
Dornkaulstr.
2
52134 Herzogenrath
Germany
(Address of principal executive
offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ⊠ |
Form 40-F ⃞ |
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ⃞ |
No ⊠ |
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): N/A
AIXTRON SE: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Notification of voting rights pursuant to Art. 25a, Sec. 1 WpHG We received the following notification pursuant to Art. 25a, Sec. 1 WpHG on May 29, 2015:
1. Listed company: AIXTRON SE, Dornkaulstraße 2, 52134 Herzogenrath, Germany
2. Notifier: Credit Suisse Group AG, Zurich, Switzerland
3. Triggering event: Falling below threshold
4. Threshold(s) crossed or reached: 5%
5. Date at which the threshold is crossed or reached: 25.05.2015
6. Total amount of voting rights: 4.91% (equals 5531282 voting rights) calculated from the following total number of voting rights issued: 112701905
7. Detailed information on the voting rights proportion: Voting rights proportion based on financial/other instruments pursuant to Art. 25a, Sec. 1 WpHG: 0.57% (equals 641889 voting rights) thereof held indirectly: 0.57% (equals 641889 voting rights) Voting rights proportion based on financial/other instruments pursuant to Art. 25 WpHG: 3.23% (equals 3637961 voting rights) thereof held indirectly: 3.23% (equals 3637961 voting rights) Voting rights pursuant to Art. 21, 22 WpHG: 1.11% (equals 1251432 voting rights)
8. Detailed information on financial/other instruments pursuant to Art. 25a, Sec. 1 WpHG:
Chain of controlled undertakings:
Credit Suisse AG, Credit Suisse Investments (UK), Credit Suisse Investment Holdings (UK), Credit Suisse Securities (Europe) Limited
ISIN or name/description of the financial/other instrument: Equity Swap, Cash Settlement, Expiration date: 02.06.2015
ISIN or name/description of the financial/other instrument: Equity Swap, Cash Settlement, Expiration date: 05.06.2015
ISIN or name/description of the financial/other instrument: Equity Swap, Cash Settlement, Expiration date: 05.05.2016
ISIN or name/description of the financial/other instrument: Equity Swap, Cash Settlement, Expiration date: 02.06.2016
ISIN or name/description of the financial/other instrument: Equity Swap, Cash Settlement, Expiration date: 30.09.2016
ISIN or name/description of the financial/other instrument: Equity Swap, Cash Settlement, Expiration date: 03.10.2016
ISIN or name/description of the financial/other instrument: Equity Swap, Cash Settlement, Expiration date: 02.02.2017
ISIN or name/description of the financial/other instrument: Equity Swap, Cash Settlement, Expiration date: 18.09.2017
Furthermore, we received the following notification pursuant to Art. 25a, Sec. 1 WpHG on May 29, 2015:
1. Listed company: AIXTRON SE, Dornkaulstraße 2, 52134 Herzogenrath, Germany
2. Notifier: Credit Suisse AG, Zurich, Switzerland
3. Triggering event: Falling below threshold
4. Threshold(s) crossed or reached: 5%
5. Date at which the threshold is crossed or reached: 25.05.2015
6. Total amount of voting rights: 4.91% (equals 5531282 voting rights) calculated from the following total number of voting rights issued: 112701905
7. Detailed information on the voting rights proportion: Voting rights proportion based on financial/other instruments pursuant to Art. 25a, Sec. 1 WpHG: 0.57% (equals 641889 voting rights) thereof held indirectly: 0.57% (equals 641889 voting rights) Voting rights proportion based on financial/other instruments pursuant to Art. 25 WpHG: 3.23% (equals 3637961 voting rights) thereof held indirectly: 2.41% (equals 2717794 voting rights) Voting rights pursuant to Art. 21, 22 WpHG: 1.11% (equals 1251432 voting rights)
8. Detailed information on financial/other instruments pursuant to Art. 25a, Sec. 1 WpHG:
Chain of controlled undertakings:
Credit Suisse Investments (UK), Credit Suisse Investment Holdings (UK), Credit Suisse Securities (Europe) Limited
ISIN or name/description of the financial/other instrument: Equity Swap, Cash Settlement, Expiration date: 02.06.2015
ISIN or name/description of the financial/other instrument: Equity Swap, Cash Settlement, Expiration date: 05.06.2015
ISIN or name/description of the financial/other instrument: Equity Swap, Cash Settlement, Expiration date: 05.05.2016
ISIN or name/description of the financial/other instrument: Equity Swap, Cash Settlement, Expiration date: 02.06.2016
ISIN or name/description of the financial/other instrument: Equity Swap, Cash Settlement, Expiration date: 30.09.2016
ISIN or name/description of the financial/other instrument: Equity Swap, Cash Settlement, Expiration date: 03.10.2016
ISIN or name/description of the financial/other instrument: Equity Swap, Cash Settlement, Expiration date: 02.02.2017
ISIN or name/description of the financial/other instrument: Equity Swap, Cash Settlement, Expiration date: 18.09.2017
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
AIXTRON SE |
||||
|
||||
|
||||
Date: | June 3, 2015 |
By: |
/s/ Martin Goetzeler |
|
Name: |
Martin Goetzeler |
|||
Title: |
President and CEO |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CIDARA Therapeutics ALERT: Bragar Eagel & Squire, P.C. is Investigating Cidara Therapeutics, Inc. on Behalf of Cidara Therapeutics Stockholders and Encourages Investors to Contact the Firm
- ENDEAVOR ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of EDR and Encourages Investors to Contact the Firm
- ROSEN, A LEADING LAW FIRM, Encourages VinFast Auto Ltd. f/k/a Black Spade Acquisition Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VFS
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!